Clinical Trial Update: HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI) [Phase 2]

View source ↗

Summary

Phase 2 trial of HT-0712 versus placebo in Age-Associated Memory Impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-associated Memory Impairment

Drugs mentioned

• HT-0712

Snippet

Sponsor: Dart NeuroScience, LLC | Conditions: Age-Associated Memory Impairment (AAMI) | Phase 2 | Status: COMPLETED